坚宝国际(00675.HK)中期纯利升78.52%至245.21万港元
格隆汇8月27日丨坚宝国际(00675.HK)公布,截2019至年6月30日止中期,公司实现收益1.81亿港元,同比减少21.67%;毛利3261.55万港元,同比减少10.13%;公司拥有人所占期间溢利245.21万港元,同比增长78.52%;每股盈利0.92港仙。
集团上半年整体毛利率较去年同期增加2.3%至18.0%。毛利率改善的主要原因包括:人民币汇价较去年同期疲弱而减轻于中国大陆的生产成本、整合客户及产品组合的改变。因为上述终止业务的影响,销售及经销成本及行政费用分别减少14.7%及13.2%至约1270万港元及1340万港元。融资成本减少约10万港元至约70万港元
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.